Revenue of $3.9 million up 66% over prior year, product revenue of $2.9 million up 23%
Pipeline of 924 MyoPro candidates up 14% over fourth quarter of 2021
Conference call begins at 4:30 p.m. Eastern time today
BOSTON (May 11, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2022. Read more.